William Woods
Stock Analyst at B. Riley Securities
(1.62)
# 3,284
Out of 5,170 analysts
14
Total ratings
46.67%
Success rate
-3.74%
Average return
Main Sectors:
Stocks Rated by William Woods
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KRMD KORU Medical Systems | Maintains: Buy | $7 → $8 | $4.30 | +86.05% | 2 | Mar 13, 2026 | |
| ALT Altimmune | Maintains: Buy | $18 → $13 | $3.42 | +280.12% | 1 | Mar 6, 2026 | |
| PALI Palisade Bio | Initiates: Buy | $7 | $1.99 | +251.76% | 1 | Jan 9, 2026 | |
| MDGL Madrigal Pharmaceuticals | Maintains: Buy | $560 → $670 | $454.22 | +47.51% | 1 | Dec 11, 2025 | |
| OKYO OKYO Pharma | Initiates: Buy | $5 | $1.62 | +208.64% | 1 | Dec 8, 2025 | |
| CGTX Cognition Therapeutics | Reiterates: Buy | $2 → $3 | $1.08 | +177.78% | 1 | Nov 21, 2025 | |
| LFMD LifeMD | Maintains: Buy | $12 → $10 | $4.09 | +144.50% | 3 | Nov 18, 2025 | |
| IMUX Immunic | Reiterates: Buy | $6 → $5 | $1.16 | +331.03% | 3 | May 23, 2025 | |
| VERU Veru Inc. | Initiates: Buy | $50 | $2.30 | +2,073.91% | 1 | May 14, 2024 |
KORU Medical Systems
Mar 13, 2026
Maintains: Buy
Price Target: $7 → $8
Current: $4.30
Upside: +86.05%
Altimmune
Mar 6, 2026
Maintains: Buy
Price Target: $18 → $13
Current: $3.42
Upside: +280.12%
Palisade Bio
Jan 9, 2026
Initiates: Buy
Price Target: $7
Current: $1.99
Upside: +251.76%
Madrigal Pharmaceuticals
Dec 11, 2025
Maintains: Buy
Price Target: $560 → $670
Current: $454.22
Upside: +47.51%
OKYO Pharma
Dec 8, 2025
Initiates: Buy
Price Target: $5
Current: $1.62
Upside: +208.64%
Cognition Therapeutics
Nov 21, 2025
Reiterates: Buy
Price Target: $2 → $3
Current: $1.08
Upside: +177.78%
LifeMD
Nov 18, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $4.09
Upside: +144.50%
Immunic
May 23, 2025
Reiterates: Buy
Price Target: $6 → $5
Current: $1.16
Upside: +331.03%
Veru Inc.
May 14, 2024
Initiates: Buy
Price Target: $50
Current: $2.30
Upside: +2,073.91%